Tuesday, September 08, 2020 12:29:50 PM
I know they are hard at work, with a Really good Science staff at the U-Of-Michigan, but reaching for a product that does more than what the original CHS patent(s) can do, is asking a lot, IMO? The product seems to be rather simple, but good research Chemists will be needed to find the elements and molecules that add to the CHS, not just merely Quantify some elemental inclusions in what the CHS product has, but Qualitatively improve the product in some important way?
I don't know any more than that, but I do know, that perseverance and Love of product, and it seems they have that, could hit pay-dirt in time? Also, what would the boys do if the Co' collapses, something all of them have in mind? Their options are limited, so development of the CHS is of the highest priority, or all of them could be out on the streets?
Looking back when they had the contract with NDSU, the boys were able to convince a number of manufacturers to the value of the CHS product, but ran into wall after wall of roadblocks, where some of them might still exist today even if they had a better CHS Patent?
Testing to the needs of a manufacturer who they might have an agreement with, digging deeper into the pockets of the Investors, being able to re-tool, or make changes to the product, all might come into play again? Hey, the Boys have lost a lot of weight because of the money crunch, so how long can they hold out on the mini-Burgers at Mc's?
Recent CRTG News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:51:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:40:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:38:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2023 08:36:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 12:24:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM